Cardiologist, entrepreneur, author. Medical device inventor, JNJ stent, chemical renal denervation, ... Director interventional cardiology fellowship MSU.
Carmel, CA
Joined November 2012
- Tweets133
- Following78
- Followers339
- Likes30
Looking for a few great fellows for 2026. Please get a hold of Rochelle to have a great interventional training experience.
Tim A. Fischell, M.D retweeted
What makes a great interventional cardiology fellowship?
linkedin.com/posts/rochelle-…
@drvishalg @jagskalavakunta @Abi_sood @TakeshiNishiMD @HusamShadidMD @mustr1475 @ACCinTouch @CardioNerds @TCTMD @SCAI
Statins should probably be taken qod as this has ~95% of the efficacy and probably 10% the incidence of myalgia.
Hi Mo. I have a Great technology that you may be interested in to highlight on innovation nation. It is the newly FDA approved implantable heart attack detector and alerting system. Pretty cool technology. I think it would be a great story. Tim
Hi Mo. I am a great fan of yours and innovation nation. I was trying to figure out how to get a hold of you. There is a great technology of implantable heart attack detection, now FDA approved by a company AngelMed . I think it would be a great story for IN.
Tim A. Fischell, M.D retweeted
#mdpijcm
📢Happy to share the #Review "The Potential Role of #RenalDenervation in the Management of #HeartFailure" @AKassier @TimAFischellMD
🧐Full text: mdpi.com/2077-0383/11/14/414…
Very excited about the upcoming CICT meetings in Pasadena, July 14-16. Great agenda and fabulous faculty. Would love to see everyone there!
Shout out to Senator Mark Kelly (@SenMarkKelly). Amazing help by Senator and his office (Amy) to assist getting my brother-in-law, Vitaliy and family, from Ukraine, into US on Wed. Cannot thank him and staff enough!!!
Agreed. Remember, Pfizer did not even take any federal money. This is their researchers and scientists doing amazing science. This has nothing directly to do with Donald Trump and it certainly was not “a miracle.”
Tim A. Fischell, M.D retweeted
1st randomized patient at St Johns Hospital in Detroit with @PADguy60 in the TARGET BP1 Study! Pre randomization angio in a 1:1 Sham vs ETOH Denervation. What are your thoughts about Sham controlled? Making HTN fun! #RCT #Clinicalresearch @Ascension_MI – at Detroit, MI
Two major articles have been published in the last year. The first was the original analysis with Michael Gibson as the lead author in JACC reporting the ALERTS data. The other, Holmes paper, showed a dramatic decrease in time to arrival for ACS with AngelMed Guardian.
That is great that intraconary epinephrine works. I would love to see a head to head with intra-coronary nicardipine. Truly a magic drug for no reflow!
Great to see AngelMed Starting to gain traction. Hopefully we will hear a lot more about it including in the US and outside the US in the next year. It has been a long and arduous process but I think this could be as they say in the TV piece here “a game changer.”
Hundreds of lives could be saved by a new device that can warn if you're about to have a heart attack. The implant monitors the beat of a patient’s heart rhythm, providing a vital early alert that something might not be right. 7NEWS.com.au @JackieQuist7 #7NEWS